Tag: GLP-1
GLP-1 drugs like Ozempic may now be an option for a group of patients long left out
The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.
Ozempic may cut your asthma attack risk by nearly 40%
New research links semaglutide, the drug in Ozempic and Wegovy, to sharply fewer asthma attacks.
Weight-loss drugs may slow cancer from spreading in the body, large data shows
Data from more than 12,000 cancer patients points to a new benefit of GLP-1 drugs.
FDA approves the first weight-loss pill you can take any time, without food restrictions
A new daily GLP-1 pill drops the fasting window that has frustrated Rybelsus users.
If you take Ozempic or Wegovy, these foods may make side effects much worse
The mechanism that curbs appetite is the same one that turns some meals into hours of nausea.
On Ozempic or Wegovy? Data shows your daily steps may be dropping without you knowing
A Fitbit-tracked analysis of 753 adults suggests movement quietly falls after starting a GLP-1.